Literature DB >> 21938539

A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.

A M Hoegh1, J B Nielsen, A Lester, A Friis-Møller, K Schønning.   

Abstract

The purpose of this study was to validate a multiplex real-time PCR assay capable of detecting toxigenic Clostridium difficile and simultaneously identifying C. difficile ribotype 027/ST-1 by targeting the toxin genes tcdA, tcdB and cdtA in one reaction and in a separate reaction identifying the Δ117 deletion in tcdC associated with ribotype 027/ST-1. PCR was done prospectively on 704 samples routinely submitted to our department and results were compared to results of toxigenic culture. Sequencing of tcdC, multi locus sequence typing (MLST) and PCR ribotyping were done on cultured isolates to confirm the correct identification of the Δ117 deletion in tcdC and C. difficile ribotype 027/ST-1, respectively. The PCR assay displayed a sensitivity, specificity, PPV and NPV of 99.0%, 97.4%, 87.4% and 99.8%, respectively, compared to toxigenic culture on 665 samples evaluable both by PCR and culture. Sequencing of tcdC, ribotyping and MLST of cultured isolates validated the genotyping assay and confirmed the ability of the assay to correctly identify C. difficile ribotype 027/ST-1 in our current epidemiological setting. We describe the use of a combination of two separate PCR assays for sensitive and specific detection of toxigenic C. difficile and presumptive identification of C. difficile 027/ST-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21938539     DOI: 10.1007/s10096-011-1409-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Evaluation of a rapid molecular screening approach for the detection of toxigenic Clostridium difficile in general and subsequent identification of the tcdC Δ117 mutation in human stools.

Authors:  R F de Boer; J J Wijma; T Schuurman; J Moedt; B G Dijk-Alberts; A Ott; A M D Kooistra-Smid; Y T H P van Duynhoven
Journal:  J Microbiol Methods       Date:  2010-07-30       Impact factor: 2.363

2.  Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.

Authors:  P Bidet; F Barbut; V Lalande; B Burghoffer; J C Petit
Journal:  FEMS Microbiol Lett       Date:  1999-06-15       Impact factor: 2.742

3.  Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.

Authors:  Paul D Stamper; Romina Alcabasa; Deborah Aird; Wisal Babiker; Jennifer Wehrlin; Ijeoma Ikpeama; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

4.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

Review 6.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).

Authors:  M J T Crobach; O M Dekkers; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

7.  Evaluation of a new commercial TaqMan PCR assay for direct detection of the clostridium difficile toxin B gene in clinical stool specimens.

Authors:  Paul D Stamper; Wisal Babiker; Romina Alcabasa; Deborah Aird; Jennifer Wehrlin; Ijeoma Ikpeama; Linda Gluck; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

Review 8.  Clostridium difficile toxin synthesis is negatively regulated by TcdC.

Authors:  B Dupuy; R Govind; A Antunes; S Matamouros
Journal:  J Med Microbiol       Date:  2008-06       Impact factor: 2.472

9.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

10.  Clinical Clostridium difficile: clonality and pathogenicity locus diversity.

Authors:  Kate E Dingle; David Griffiths; Xavier Didelot; Jessica Evans; Alison Vaughan; Melina Kachrimanidou; Nicole Stoesser; Keith A Jolley; Tanya Golubchik; Rosalind M Harding; Tim E Peto; Warren Fawley; A Sarah Walker; Mark Wilcox; Derrick W Crook
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

View more
  7 in total

1.  Routine disc diffusion antimicrobial susceptibility testing of Clostridium difficile and association with PCR ribotype 027.

Authors:  H M Holt; T K Danielsen; U S Justesen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-30       Impact factor: 3.267

2.  A 5' Nuclease Genotyping Assay for Identification of Macrolide-Resistant Mycoplasma genitalium in Clinical Specimens.

Authors:  Gitte Qvist Kristiansen; Jan Gorm Lisby; Kristian Schønning
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

3.  Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool.

Authors:  Bin Huang; Dazhi Jin; Jing Zhang; Janet Y Sun; Xiaobo Wang; Jeffrey Stiles; Xiao Xu; Mini Kamboj; N Esther Babady; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

4.  Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.

Authors:  M B F Jensen; K E P Olsen; X C Nielsen; A M Hoegh; R B Dessau; T Atlung; J Engberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-25       Impact factor: 3.267

5.  Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples.

Authors:  Abdullah Kilic; Mohammad J Alam; Naradah L Tisdel; Dhara N Shah; Mehmet Yapar; Todd M Lasco; Kevin W Garey
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

6.  A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults.

Authors:  Colleen S Kraft; J Scott Parrott; Nancy E Cornish; Matthew L Rubinstein; Alice S Weissfeld; Peggy McNult; Irving Nachamkin; Romney M Humphries; Thomas J Kirn; Jennifer Dien Bard; Joseph D Lutgring; Jonathan C Gullett; Cassiana E Bittencourt; Susan Benson; April M Bobenchik; Robert L Sautter; Vickie Baselski; Michel C Atlas; Elizabeth M Marlowe; Nancy S Miller; Monika Fischer; Sandra S Richter; Peter Gilligan; James W Snyder
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

7.  Evaluating next-generation sequencing for direct clinical diagnostics in diarrhoeal disease.

Authors:  K G Joensen; A L Ø Engsbro; O Lukjancenko; R S Kaas; O Lund; H Westh; F M Aarestrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-11       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.